Eric Gordon

Dr. Gordon is the Medical Director of Gordon Medical Associates and a consulting expert in complex, chronic illness, known for working with patients whose cases defy conventional diagnosis by identifying the correct sequence of treatment using the latest research, advanced technologies, and more than 45 years of clinical experience in autoimmune conditions, mitochondrial dysfunction, tick-borne diseases, and related disorders. In addition to his clinical practice, he is President of the Gordon Medical Research Center, where he brings together leading international researchers and clinicians focused on ME/CFS, Lyme disease, and autoimmune disease, and he is a frequent invited speaker for organizations including ILADS, Infectolab-Americas, and ISEAI. Dr. Gordon is also internationally recognized for his research collaborations, notably co-authoring Dr. Robert Naviaux’s landmark 2016 PNAS study, Metabolic Features of Chronic Fatigue Syndrome, which advanced understanding of metabolomics, mitochondrial function, and chronic inflammatory disease.